Table I.
Clinicopathological characteristics of the patients and tumors.
| Surgically resected cancers (n=44)
|
Far advanced cancers (n=20)
|
|||
|---|---|---|---|---|
| Parameter | n (%) | n (%) | ||
| Age (mean ± SD, years) | 63.3±3.7 | 57.3±5.7 | ||
| <65 | 23 (52) | 13 (65) | ||
| ≥65 | 21 (47) | 7 (35) | ||
| Gender | ||||
| Male | 34 (77) | 16 (80) | ||
| Female | 10 (23) | 4 (20) | ||
| Tumor site | ||||
| Head | 36 (82) | 12 (60) | ||
| Body and/or tail | 8 (18) | 8 (40) | ||
| Stage | ||||
| I | 1 (2) | |||
| II | 32 (73) | |||
| III | 8 (18) | |||
| IV | 3 (7) | |||
| Grade | ||||
| 1 | 12 (27) | 5 (25)a | 2 (10)b | |
| 2 | 28 (64) | 3 (15)a | 9 (45)b | |
| 3 | 4 (9) | 12 (60)a | 9 (45)b | |
| Median survival (mean ± SD, month) | 24.5±10.3 | |||
a
Primary cancers.
b
Hepatic metastases. SD, standard deviation.